Earthworks Industries Inc. (TSXV:EWK)

Intra-Cellular Therapies Income Statement

Financials in millions CAD. Fiscal year is December - November.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 31, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021	Nov 30, 2020
Selling, General & Admin	1.52	1.43	0.82	1.36	0.59	0.51
Operating Expenses	1.52	1.43	0.82	1.36	0.59	0.51
Operating Income	-1.52	-1.43	-0.82	-1.36	-0.59	-0.51
Interest Expense	-0.97	-0.92	-0.34	-0.56	-0.42	-0.46
Other Non Operating Income (Expenses)	-0.02	-0.04	0.02	0.02	-0.04	-0.05
EBT Excluding Unusual Items	-2.52	-2.39	-1.14	-1.9	-1.05	-1.02
Asset Writedown	-12.06	-12.06	-	-	-	-
Other Unusual Items	-0.68	-0.68	3.78	0.06	-	-
Pretax Income	-15.26	-15.13	2.65	-1.84	-1.05	-1.02
Income Tax Expense	-0.01	-0.01	0.38	-	-	-
Net Income	-15.25	-15.12	2.27	-1.84	-1.05	-1.02
Net Income to Common	-15.25	-15.12	2.27	-1.84	-1.05	-1.02
Shares Outstanding (Basic)	122	112	97	91	81	79
Shares Outstanding (Diluted)	122	112	101	91	81	79
Shares Change (YoY)	20.82%	9.93%	11.92%	12.01%	2.30%	10.78%
EPS (Basic)	-0.13	-0.14	0.02	-0.02	-0.01	-0.01
EPS (Diluted)	-0.13	-0.14	0.02	-0.02	-0.01	-0.01
Free Cash Flow	-1.56	-1.32	-1.26	-0.38	-0.55	-0.45
Free Cash Flow Per Share	-0.01	-0.01	-0.01	-0.00	-0.01	-0.01
EBITDA	-1.52	-1.43	-0.82	-1.36	-0.59	-0.51
D&A For EBITDA	0	0	0	0	0	0
EBIT	-1.52	-1.43	-0.82	-1.36	-0.59	-0.51
Effective Tax Rate	-	-	14.25%	-	-	-
Advertising Expenses	-	0.03	0.01	0	0	0

Source: S&P Global Market Intelligence. Standard template. Financial Sources.